Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Salix seeks marketing extension for ulcerative colitis drug
The company is attempting to take advantage of an FDA scheme that extends a product’s period of exclusivity if a company conducts tests to prove the safety and
The company is attempting to take advantage of an FDA scheme that extends a product’s period of exclusivity if a company conducts tests to prove the safety and
The product candidate is currently in clinical development for the treatment of chronic middle ear infection, and is also showing potential in other indications such as sinusitis and
The drug was also shown to be effective with a favorable safety profile in three pivotal studies published in the Journal of the American Medical Association. Data show
The company filed for the commencement of insolvency proceedings at a court in Wurzburg, Germany, stating that the adverse reactions caused by TGN1412 in the phase I trial
If successful, the drug, currently known as MED2002, would be the world’s first non-prescription pharmaceutical treatment for men with erectile dysfunction (ED). Under the terms of the agreement,
The Kaletra (lopinavir/ritonavir) tablet allows adult patients to take fewer pills with or without food as part of their treatment regimen while maintaining the same safety and efficacy.
The product (lamivudine-zidovudine-nevirapine tablet) contains the active ingredients in GlaxoSmithKline’s Epivir (lamivudine) and Retrovir (zidovudine), and Boehringer Ingelheim’s Viramune (nevirapine), all widely used antiretroviral drugs. The agency’s tentative
The bill, named the Dietary Supplement and Nonprescription Drug Consumer Act, is expected to go to the Senate floor for a vote in mid-July. Citizens for Health said
The four organizations are the World Health Organization (WHO), the Joint United Nations Programme on HIV/AIDS (UNAIDS), the Global Fund to Fight AIDS, Tuberculosis and Malaria, and the
Mohammed Azim Dad from Slough, UK pleaded guilty to three counts under the Trade Marks Act 1994 relating to counterfeit Viagra, Cialis and Levitra at Reading crown court.